Back
Caribou Biosciences Quote, Financials, Valuation and Earnings
Sponsored
CRBU
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
49
CRBU
Caribou Biosciences
Last Price:
2.07
Seasonality Move:
-21.17%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.Caribou Biosciences Price Quote
$2.07
+0.01 (+0%)
(Updated: September 21, 2024 at 6:18 AM ET)
Caribou Biosciences Key Stats
Sell
49
Caribou Biosciences (CRBU)
is a Sell
Day range:
$1.99 - $2.10
52-week range:
$1.50 - $8.33
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.47
P/B ratio:
0.6%
Volume:
1.1M
Avg. volume:
941.3K
1-year change:
-60.91%
Market cap:
$186.1M
Revenue:
$34.5M
EPS:
$-1.4
How Much Does Caribou Biosciences Make?
-
How Much Are Caribou Biosciences's Sales Annually?
CRBU Revenues are $34.5M -
How Much Profit Does Caribou Biosciences's Make A Year?
CRBU net income is -$102.1M
Is Caribou Biosciences Growing As A Company?
-
What Is Caribou Biosciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.08% -
What Is Caribou Biosciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Caribou Biosciences Stock Price Performance
-
Did Caribou Biosciences Stock Go Up Last Month?
Caribou Biosciences share price went down by -3.29% last month -
Did CRBU's Share Price Rise Over The Last Year?
CRBU share price fell by -60.91% over the past 1 year
What Is Caribou Biosciences 52-Week High & Low?
-
What Is Caribou Biosciences’s 52-Week High Share Price?
Caribou Biosciences has traded as high as $8.33 over the past 52 weeks -
What Is Caribou Biosciences’s 52-Week Low Share Price?
Caribou Biosciences has traded as low as $1.50 over the past 52 weeks
Caribou Biosciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Caribou Biosciences?
-
How Much Debt Does Caribou Biosciences Have?
Total long term debt quarterly is $0 -
How Much Cash Does Caribou Biosciences Have?
Cash and short term investments quarterly total is $261.6M -
What Is Caribou Biosciences’s Book Value Per Share?
Book value per share is 3.44
Is Caribou Biosciences Cash Flow Positive?
-
What Is CRBU Cash Flow From Operations?
Cash flow from operations (TTM) is -$120.2M -
What Is Caribou Biosciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $147.7M -
What Is Caribou Biosciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$55.8M
Caribou Biosciences Return On Invested Capital
-
Is Management Doing A Good Job?
CRBU return on invested capital is -36.52% -
What Is Caribou Biosciences Return On Assets?
ROA measures how assets are converting to revenues and is -30.57% -
What Is CRBU Return On Equity?
ROE is a measure of profitability and is -36.52%
Caribou Biosciences Earnings Date & Stock Price
-
What Is Caribou Biosciences's Stock Price Today?
A single share of CRBU can be purchased today for 2.06 -
What Is Caribou Biosciences’s Stock Symbol?
Caribou Biosciences trades on the nasdaq under the ticker symbol: CRBU -
When Is Caribou Biosciences’s Next Earnings Date?
The next quarterly earnings date for Caribou Biosciences is scheduled on November 7, 2024 -
When Is CRBU's next ex-dividend date?
Caribou Biosciences's next ex-dividend date is September 21, 2024 -
How To Buy Caribou Biosciences Stock?
You can buy Caribou Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Caribou Biosciences Competitors
-
Who Are Caribou Biosciences's Competitors?
Below is a list of companies who compete with Caribou Biosciences or are related in some way:
Caribou Biosciences Dividend Yield
-
What Is CRBU Dividend Yield?
Caribou Biosciences’s dividend yield currently is 0% -
What Is Caribou Biosciences’s Payout Ratio?
Caribou Biosciences’s payout ratio is 0% -
When Did Caribou Biosciences Last Pay A Dividend?
The latest dividend pay date is September 21, 2024 -
What Is Caribou Biosciences’s Dividend Per Share?
Caribou Biosciences pays a dividend of $0.00 per share
Caribou Biosciences Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0.91% |
Revenue: | -7.75% | 14.01% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 15.63 |
Upside from Last Price: | 658.5% |